Cold agglutinin disease (CAD) is a rare subtype of autoimmune haemolytic anaemia (AIHA) where autoantibodies, predominantly of the IgM class, bind to red blood cells at reduced temperatures. This ...

Enjaymo is the first-and-only approved therapeutic option approved for hemolytic anemia in adult patients with cold agglutinin disease Paris, November 17, 2022. The European Commission (EC) has ...

/ -- Autoimmune hemolytic anemia (AIHA) treatment encompasses a range of therapeutic strategies aimed at mitigating the immune system's attack on red blood cells, thereby alleviating anemia and ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Anemia and hemolytic anemia are both conditions that result in too few red blood cells (RBCs). Their causes are different, but both have similar symptoms and can lead to long-term complications. Share ...

Microangiopathic hemolytic anemia (MAHA) occurs when turbulence in the blood destroys red blood cells. This leads to symptoms such as tiredness and shortness of breath. Certain treatments are ...

In early-onset severe hemolytic disease of the fetus and newborn (HDFN), transplacental transfer of maternal antierythrocyte IgG alloantibodies causes fetal anemia that leads to the use of high-risk ...